In this interview we discuss new data on the use of radiotherapy in cancer patients with brain metastases.
In this interview we discuss the effect of the gut microbiome on responses and survival outcomes in metastatic melanoma patients treated with anti–PD-1 immunotherapies.
In this interview we discuss how relapse in multiple myeloma manifests and treatment options for relapsed/refractory patients.
Dr. Karen Reckamp talks about ways to incorporate biomarkers for the treatment of lung cancer with immunotherapy into clinical practice at the 2017 American Society of Clinical Oncology Annual Meeting, held June 2–6 in Chicago.
As part of our coverage of the 2017 ASCO Annual Meeting, we discuss homologous recombination deficiency in ovarian cancer and PARP inhibitors.
In this interview we discuss decision making in the treatment of metastatic renal cell carcinoma.
Ahead of the 2017 ASCO Annual Meeting, we discuss the discontinuation of TKIs in some chronic myeloid leukemia patients.
In this interview ahead of ASCO 2017 we discuss the physical and cognitive effects of androgen deprivation therapy in older men treated for prostate cancer.
Ahead of the 2017 ASCO Annual Meeting, we discuss how to approach treatment for older patients with lung cancer.
With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way
In this interview we discuss important developments in the diagnosis and management of breast cancer and more.